Aggarwal Sumit bought ELOX

October 16, 2024 · Form 4 insider transaction

Aggarwal Sumit bought 42,790 shares of Eloxx Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 569 days after the transaction.

Direction
Acquired (buy-side)
Shares
42,790
Price
N/A
Total value
N/A
RoleOfficer, Director, 10% owner
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 16, 2024
Filing dateMay 8, 2026
Shares owned after42,790
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The reporting person agreed to cancellation of an option granted to him on February 6, 2022 in exchange for a new option having a lower exercise price.; The stock option vested and became exercisable over the four-year period commencing February 6, 2022, with one-fourth of the shares of common stock underlying the options vesting on February 6, 2023, and the remainder vesting in twelve equal quarterly installments thereafter. The Board accelerated vesting on the unvested portion in connection with the exercise.

View the original Form 4 on SEC EDGAR